Bleeding reduction during secondary prophylaxis with bypassing agents in inhibitor patients

Thromb Res. 2011 Feb;127(2):174-5. doi: 10.1016/j.thromres.2010.06.031. Epub 2010 Sep 1.
No abstract available

Publication types

  • Kommentar
  • Letter

MeSH terms

  • Hemophilia A / blood
  • Hemophilia A / therapy*
  • Hemorrhage / therapy
  • Hemostasis*
  • Hemostatics / therapeutic use*
  • Humans
  • Treatment Outcome

Substances

  • Hemostatics